The increased IL-6 in COVID-19 patients can bind to the glycoprotein (gp130) receptor and IL-6 receptor, thereby facilitating the downstream activation of JAK/STAT signaling (Catanzaro et al., 2020; Zhang et al., 2020). Here, SOAT1 is linked to COVID-19.